Transcription of Actilax - Medicines
{{id}} {{{paragraph}}}
Actilax Lactulose PRODUCT INFORMATION NAME OF THE MEDICINE Active ingredient: Lactulose Structural formula: Molecular formula: C12H22O11 Mol. Wt. CAS Registry no.: 4618-18-2 DESCRIPTION Lactulose solution is an aqueous solution of lactulose (4-O- -D-galacto-pyranosyl-D-fructose) and other sugars including lactose, galactose, tagatose and epilactose. Each 5 mL contains lactulose g, and lesser amounts of other sugars including lactose, galactose, tagatose and epilactose. Actilax solution is a sweet, colourless to slightly brownish-yellow, clear or slightly opalescent solution. PHARMACOLOGY Therapeutic category. Laxative Experimental data on lactulose given orally to man indicate that lactulose is poorly absorbed from the gastrointestinal tract and no enzymes capable of hydrolysis of lactulose into its component monosaccharides are known to be present in human gastrointestinal tissue. Lactulose reaches the colon virtually unchanged.
Actilax – Product Information 6 Paediatric Population: The safety profile in children is expected to be similar as in adults. DOSAGE AND ADMINISTRATION The lactulose solution may be administered diluted or undiluted.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
COLI: EFFECT ON RESTRICTION, COLI: EFFECT ON RESTRICTION ENZYMES, Restriction, Coli, Effect, And bacterial expression system optimization, Tricks to Success and Interpretation, Results for Foodborne Outbreak Investigations, SIDS Initial Assessment Report For SIAM, Review CRISPR-Cas9: from Genome Editing, Disinfection, UNIVERSITY OF MUMBAI